BioSpace News Archive

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4th, 2020.

Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that it has issued an aggregate of 5,594,593 shares of common stock at a price of $92.50 per share at the closing of the Company’s previously-announced public offering.

Avantor, Inc. announced the pricing of the previously announced private offering by its wholly-owned subsidiary, Avantor Funding, Inc., of $1.550 billion aggregate principal amount of 4.625% Senior Notes due 2028 and €400 million aggregate principal amount of 3.875% Senior Notes due 2028.

Tower Health and Drexel University, which in partnership own and operate St. Christopher’s Hospital for Children, announced that Donald Mueller will become the new Chief Executive Officer for St. Christopher’s, effective July 27, 2020.

Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Bob Goeltz will join Arcus as Chief Financial Officer on August 1, 2020

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2020 results after the financial markets close on Thursday, July 30, 2020.

Ridgeback Biotherapeutics announces the start of enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801.

Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced the successful completion of the refinancing of its capital structure

EmbedTek, LLC, a technology (IoT) company specializing in the design and manufacture of embedded computer systems, software, sensors, and integrated displays, announced today that it has begun production and is accepting orders for PariRange™, a peer-to-peer social distancing and contact tracing device.

VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has completed the solicitation of an in-court prepackaged plan of reorganization, under which IEH Biopharma LLC (“IEH”) will take 100% ownership of VIVUS (the “Prepackaged Plan”), ahead of its July 7, 2020 chapter 11 filing.